Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Stock pick for 2024: Just Group is so cheap and has big growth drivers behind it

Annuities and lifetime mortgage specialist Just Group (JUST) looks screamingly cheap at its current price. We think 2024 will see a rerating from its current low single-digit PE (price to earnings) ratio with the company confident of hitting its 15% underlying operating profit growth target in 2023.
This profit growth should underpin growth in dividends at a similar level, particularly given the company’s actions to reduce balance sheet risk through interest rate hedging.
Just Group’s mission statement is to provide competitive products, financial advice and guidance to people in later life. There are growth drivers in the short, medium and long term - not least a growing over-65 population in the UK.
Right now, the company is benefiting from a strong bulk annuities market. Bulk annuities are insurance products which are sold to defined benefit schemes allowing them to transfer their risk, so that the insurance company - in this case Just Group - pays benefits to pension scheme members covered by the policy until they die.
Higher rates have made it more affordable for pension schemes to go down this road and according to Just Group only 11% of total defined benefit liabilities have been ‘de-risked’ this way - which underpins the company’s bullishness on the scale of the opportunity ahead of it.
Consultant Lane Clark & Peacock estimated in 2022 that more than £600 billion of bulk annuity deals would complete over the following 10 years. In a record first half of 2023 Just Group chalked up 35 such deals.
Individual annuities are ‘guaranteed income for life’ products which are bought by people when they reach retirement age. These have become more attractive of late, again thanks to higher interest rates.
Just Group also sells lifetime mortgage products which are effectively a type of equity release product. Any risks associated with exposure to the housing market are mitigated as the average loan to value is little more than 35%.
The shares appear to have fallen out of favour thanks to accounting changes - the new IFRS17 standard means profit on bulk and individual annuities is deferred, making it seem as if earnings have dropped off a cliff. This resulted in a 90% drop in reported 2022 profit and is expected to have a 70% to 80% impact from 2023 to 2027.
However, IFRS17 has zero impact on cash flow, capital generation or the economics of the business. As this becomes more apparent, for example as the company continues to serve up generous dividends, we would expect the market to reappraise the investment case.
Important information:
These articles are provided by Shares magazine which is published by AJ Bell Media, a part of AJ Bell. Shares is not written by AJ Bell.
Shares is provided for your general information and use and is not a personal recommendation to invest. It is not intended to be relied upon by you in making or not making any investment decisions. The investments referred to in these articles will not be suitable for all investors. If in doubt please seek appropriate independent financial advice.
Investors acting on the information in these articles do so at their own risk and AJ Bell Media and its staff do not accept liability for losses suffered by investors as a result of their investment decisions.
Issue contents
Case study
Feature
- Return from our 2023 share picks is more than four times that of the UK market
- The best and worst emerging markets in 2023
- Can electricals leader Currys deliver some turnaround spark?
- Discover the stocks the professionals changed their minds on in 2023
- Emerging markets: China property fixes and dollar weakness
Great Ideas
- 10 stocks for 2024: our best ideas for the year ahead
- Stock pick for 2024: Adobe is one of the best ways to play AI
- Stock pick for 2024: Buy Smith & Nephew for continued recovery and re-rating potential
- Stock pick for 2024: Buy Puretech Health for lower risk access to an exciting drug portfolio
- Stock pick for 2024: MongoDB is one of the hottest software plays on AI
- Stock pick for 2024: B&M's growth ambitions and value focus make it a compelling story
- Stock pick for 2024: Hunting is attractively priced and evidence of transformation is a clear catalyst
- Stock pick for 2024: The market has not spotted RELX for the AI winner it is
- Stock pick for 2024: Just Group is so cheap and has big growth drivers behind it
- Stock pick for 2024: Hollywood Bowl is a strikingly resilient operator trading at the wrong price
- Stock pick for 2024: Take advantage of this 'generational opportunity' to buy Conduit
Investment Trusts
News
- How TSMC could set the New Year tone for tech
- Markets higher despite mixed rates messaging and what to expect from retailers
- Discover the most unloved and most-shorted UK stocks
- Costco climbs to all-time high as members clamour for cheap essentials
- A big acquisition and a slowdown in its largest market have unnerved investors in Rentokil
- UK housebuilders Taylor Wimpey and Persimmon have moved-up strongly